1 unknown, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Unknown 1, Withdrawn 1 |
Follow Drug Effect: new trials by email Literature Review of Drug Effect trials Research Report on Drug Effect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mood and Cognitive Effects of Psilocybin in Healthy Participants Psilocybin, Inonotus Obliquus Whole Extract - Mood Disturbance, Mood Change | Early Phase 1 | Withdrawn | Optimi Health Corporation | 2023-01-01 | 2023-03-20 | |
| Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice treatment of drug screening - Breast Cancer, Neoadjuvant Chemotherapy | Early Phase 1 | Unknown | Peking University People's Hospital | 200 | 2019-12-01 | 2019-10-17 |
Anxiety Disorders (1) · Breast Neoplasms (1) · Parasomnias (1)
Breast Diseases (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Sleep Wake Disorders (1)
Mezlocillin (1) · Psilocybin (1)
Optimi Health Corporation (1) · Peking University People's Hospital (1)
China (1)